Kevin Sidow
CIK 1416947 · last filed 2026-06-22
Kevin Sidow is a corporate insider who has filed 9 SEC Form 4 insider transactions across 2 companies since 2008. The most recent filing, for CARL, was dated Jun 22, 2026. Across all open-market trades the lifetime net is +$200.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.20M
2
9
$200.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CARL | Director | 73,264 | $16.37 | $1.20M | $200.0K | 2 | 2026-06-22 |
| BIOFORM MEDICAL INC (BFRM) Delisted | Director | — | — | — | $0 | 7 | 2010-02-19 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-22 | CARL | Grant (A) | +13,698 | $0 | EDGAR |
| 2025-07-24 | CARL | Mixed | +59,566 | $200.0K | EDGAR |
| 2010-02-19 | BIOFORM MEDICAL INC (BFRM) Delisted | Disp (D) | — | $0 | EDGAR |
| 2009-12-29 | BIOFORM MEDICAL INC (BFRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-10-05 | BIOFORM MEDICAL INC (BFRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-07-06 | BIOFORM MEDICAL INC (BFRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-04-02 | BIOFORM MEDICAL INC (BFRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-01-06 | BIOFORM MEDICAL INC (BFRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-12-16 | BIOFORM MEDICAL INC (BFRM) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.